India Duchenne Muscular Dystrophy Drugs Market (2025-2031) | Segmentation, Industry, Companies, Forecast, Trends, Competitive Landscape, Size & Revenue, Analysis, Value, Growth, Outlook, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, 2021 & 2031F

3.3 India Duchenne Muscular Dystrophy Drugs Market - Industry Life Cycle

3.4 India Duchenne Muscular Dystrophy Drugs Market - Porter's Five Forces

3.5 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume Share, By Therapeutic Approach, 2021 & 2031F

3.7 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Duchenne Muscular Dystrophy (DMD) in India

4.2.2 Growing awareness about DMD and its treatment options

4.2.3 Advancements in medical research leading to the development of new drugs for DMD

4.2.4 Government initiatives to improve healthcare infrastructure and access to rare disease treatments

4.3 Market Restraints

4.3.1 High cost associated with DMD drugs and treatment

4.3.2 Limited availability and accessibility of specialized healthcare facilities for DMD patients

4.3.3 Challenges in diagnosis and early detection of DMD in India

4.3.4 Regulatory hurdles and delays in drug approval processes

6.1 India Duchenne Muscular Dystrophy Drugs Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F

6.1.4 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Pain Management Drugs, 2021- 2031F

6.2 India Duchenne Muscular Dystrophy Drugs Market, By Therapeutic Approach

6.2.1 Overview and Analysis

6.2.2 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Mutation Suppression, 2021- 2031F

6.2.3 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Exon Skipping, 2021- 2031F

6.2.4 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Steroid Therapy, 2021- 2031F

6.3 India Duchenne Muscular Dystrophy Drugs Market, By End User

6.3.1 Overview and Analysis

6.3.2 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Clinics, 2021- 2031F

6.3.4 India Duchenne Muscular Dystrophy Drugs Market Revenues & Volume, By Home Care Settings, 2021- 2031F

7.1 India Duchenne Muscular Dystrophy Drugs Market Export to Major Countries

7.2 India Duchenne Muscular Dystrophy Drugs Market Imports from Major Countries

8.1 Average age of diagnosis for DMD patients in India

8.2 Number of clinical trials for DMD drugs conducted in India

8.3 Percentage increase in funding for DMD research and treatment in India

8.4 Patient adherence rate to prescribed DMD drug therapies

8.5 Number of healthcare professionals trained in diagnosing and treating DMD

9.1 India Duchenne Muscular Dystrophy Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 India Duchenne Muscular Dystrophy Drugs Market Opportunity Assessment, By Therapeutic Approach, 2021 & 2031F

9.3 India Duchenne Muscular Dystrophy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 India Duchenne Muscular Dystrophy Drugs Market Revenue Share, By Companies, 2024

10.2 India Duchenne Muscular Dystrophy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters